Modulation of PMN receptors for chemotactic peptides

Schiffmann, E.; Corcoran, B.; Wahl, S.: N-formylmethionyl peptides as chemoattractants for leucocytes. Proc. natn. Acad. Sci. USA72: 1059–1062 (1975). Aswanikumar, S.; Corcoran, B.; Schiffmann, E.; Day, A.; Freer, R.; Showell, H.; Becker, E.: Demonstration of a receptor on rabbit neutrophils for chemotactic peptides. Biochem. biophys. Res. Commun.74: 810–817 (1977). Williams, L.; Synderman, R.; Pike, M.; Lefkowitz, R.: Specific receptor sites for chemotactic peptides on human polymorphonuclear leukocytes. Proc. natn. Acad. Sci. USA74: 1204–1208 (1977). Sullivan, S.; Zigmond, S.: Chemotactic peptide receptor modulation in polymorphonuclear leukocytes. J. Cell Biol.85: 703–711 (1980). Zigmond, S.; Sullivan, S.; Lauffenburger, D.: Kinetic analysis of chemotactic peptide receptor modulation. J. Cell Biol.92: 34–43 (1982). Stossel, T.: The mechanism of leukocyte locomotion; in Gallin, Quie, Leukocyte chemotaxis: methods, physiology and clinical implications, p. 143 (Raven Press, New York 1979). Gallin, J.; Gallin, E.; Schiffmann, E.: Mechanism of leukocyte chemotaxis; in Weismann, Samuelsson, Paoletti, Advances in inflammation research, vol. 1, p. 123 (Raven Press, New York 1979). Fletcher, M; Gallin, J.: Degranulating stimuli increase the availability of receptors on human neutrophils for the chemoattractant f-met-leu-phe. J. Immun.124: 1585–1588 (1980). Fletcher, M.; Seligmann, B.; Gallin, J.: Correlation of human neutrophil secretion, chemoattractant receptor mobilization, and enhanced functional capacity. J. Immun.128: 941–948 (1982). Wright, D.; Gallin, J.: Secretory responses of human neutrophils: exocytosis of specific (secondary) granules by human neutrophils during adherence in vitro and during exudation in vivo. J. Immun.123: 285–294 (1979). Van Epps, D.; Garcia, M: Enhancement of neutrophil function as a result of prior exposure to chemotactic factor. J. clin. Invest.66: 167–175 (1980). Tsung, P.; Showell, H.; Becker, E.: Surface membrane enzyme, chemotactic peptide binding activities, and chemotactic responsiveness of rabbit peripheral and peritoneal neutrophils. Inflammation4: 271–277 (1980). Fletcher, M.; Gallin, J.: Human neutrophils contain an intracellular pool of putative receptors for the chemoattractant fmet-leu-phe with a density of specific granules (submitted). Niedel, J.; Kahane, I.; Cuatrecasas, P.: Receptor-mediated internalization of fluorescent chemotactic peptide by human neutrophils. Science205: 1412–1414 (1979). Vitkauskas, G.; Showell, H.; Becker, E.: Specific binding of synthetic chemotactic peptides to rabbit peritoneal neutrophils: Effects on dissociability of bound peptide, receptor activity and subsequent biologic responsiveness (deactivation). Mol. Immunol.17: 171–180 (1980). Seligmann, B.; Fletcher, M.; Gallin, J.: Adaptation of human neutrophil responsiveness to the chemoattractant N-formylmethionyl-leucylphenyl-alanine: heterogeneity and/or negative cooperative interaction of receptors. J. biol. Chem.257: 6280–6286 (1982). Koo, C.; Lefkowitz, R.; Synderman, R.: The oligopeptide chemotactic factor receptor on human polymorphonuclear leukocyte membranes exists in two affinity in states. Biochem. biophys. Res. Commun.106: 442–449 (1981). Goetzl, E.; Foster, D.; Goldman, D.: Isolation and partial characterization of human neutrophil receptors for chemotactic formylmethionyl peptides. Biochemistry20: 5717–5722 (1981). Gallin, J.; Seligmann, B.; Fletcher, M.: Dynamics of human neutrophil receptors for the chemoattractant fmet-leu-phe. Agents Actions (in press). Gallin, J.I.; Wright, O.G.; Schiffmann, E: Role of secretory events in modulating human neutrophil chemotaxis. J. clin. Invest.62: 1363–1374 (1978). Liao, C.; Freer, R.: Cryptic receptors for chemotactic peptides in rabbit neutrophils. Biochem. biophys. Res. Commun.93: 566–571 (1980). Schiffmann, E.; Aswanikumar, S.; Venkatasubramanian, K.; Corcoran, B.; Pert, C.B.; Gross, J.B.; Day, A.R.; Freer, R.J.; Showell, H.; Becker, E: Some characteristics of the neutrophil receptor for chemotactic peptides. FEBS Lett.117: 1–7 (1980). Lohr, K.; Synderman, R.: Amphotericin B alters the affinity and functional activity of the oligopeptide chemotactic factor receptor on human polymorphonuclear leukocytes. J. Immun.129: 1594–1599 (1982). Neidel, J.; Kahane, I.; Lachman, L.; Cutrecasas, P.: A subpopulation of cultured human promyelocytic leukemia cells (HL-60) displays the formyl peptide receptor. Proc. natn. Acad. Sci. USA77: 1000–1004 (1980). Fontana, J.; Wright, D.; Schiffmann, E.; Corcoran, B.; Deisseroth, A.B.: Development of chemotactic responsiveness in myeloid precursor cells. Studies with a human leukemia cell line. Proc. natn. Acad. Sci. USA77: 3664–3668 (1980). Donabedian, H.; Gallin, J.I.: Deactivation of human neutrophil chemotaxis by chemoattractants. Effect on receptors for the chemotactic factor f-met-leu-phe. J. Immun.127: 839–844 (1981). Neidel, J.; Frothingham, R.; Cuatrecasas, P.: Inhibition of125I chemotactic peptide uptake by protease inhibitors. Biochem. biophys. Res. Commun.94: 667–673 (1980). Skubitz, K.; Craddock, P.; Hammerschmidt, D.; August, J.: Corticosteroids block binding of chemotactic peptide to its receptor on granulocytes and cause disaggregation of granulocyte aggregates in vitro. J. clin. Invest.68: 13–20 (1981). Koo, C.; Synderman, R.: Chemotactic peptide protects against inhibition by cytocholasin B of peptide winding on human polymorphonuclear leukocytes. A potential mechanism for enhanced gradient sensing. Abstract. Clin. Res.28: 373A (1980). Atkinson, J.; Simchowitz, L.; Mehta, J.; Stenson, W.F.: 5,8,11,14-Eicosatetraynoic acid (ETYA) inhibits binding of N-formyl-methionyl-leucyl-phenylalanine (FMLP) to its receptor on human granulocytes. A note of caution. Immunopharmacology4: 1–9 (1982).